Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Herrmann

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Der Nervenarzt|June 1, 1987
[Nootropic drugs: effects and effectiveness. A reflection exemplified by a phase III study using piracetam]W M Herrmann, U Kern
Neuropsychobiology|January 1, 1987
Psychotropic drug profiles: comparisons by topographic maps of absolute powerR Coppola, W M Herrmann
Comprehensive Psychiatry|April 4, 2000
Sleep-wake cycle, sleep-related disturbances, and sleep disorders: a chronobiological approachD Kunz, W M Herrmann
Zeitschrift Fur Gerontologie|September 1, 1984
[Demonstration of bencyclane effects in a clinico-pharmacologic vigilance model]W M Herrmann, U Kern
EEG-EMG Zeitschrift Fur Elektroenzephalographie, Elektromyographie Und Verwandte Gebiete|March 1, 1981
[The use of electrophysiological techniques to project typical psychotropic drug effects: some examples (author's transl)]W M Herrmann, S Kubicki
Pharmacopsychiatry|July 1, 1996
Effect and efficacy--on the function of models in controlled phase III trials and the need for prospective pharmacoepidemiological studiesG Winterer, W M Herrmann
Pharmacopsychiatria|September 1, 1983
An absolute must in clinico-pharmacological research: pharmaco-electroencephalography, its possibilities and limitationsW M Herrmann, U Irrgang
Neuropsychobiology|January 1, 1986
Combined pharmaco-EEG and pharmacopsychological study to estimate CNS effects of ketanserin in hypertensive patientsW M Herrmann, P Baumgartner
Neuropsychobiology|January 1, 1990
Event-related potentials and the prediction of differential drug response in psychiatryU Hegerl, W M Herrmann
Pharmacopsychiatry|September 1, 1988
Psychostimulants, analeptics, nootropics: an attempt to differentiate and assess drugs designed for the treatment of impaired brain functionsH Coper, W M Herrmann
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Der Nervenarzt|June 1, 1987
[Nootropic drugs: effects and effectiveness. A reflection exemplified by a phase III study using piracetam]W M Herrmann, U Kern
Neuropsychobiology|January 1, 1987
Psychotropic drug profiles: comparisons by topographic maps of absolute powerR Coppola, W M Herrmann
Comprehensive Psychiatry|April 4, 2000
Sleep-wake cycle, sleep-related disturbances, and sleep disorders: a chronobiological approachD Kunz, W M Herrmann
Zeitschrift Fur Gerontologie|September 1, 1984
[Demonstration of bencyclane effects in a clinico-pharmacologic vigilance model]W M Herrmann, U Kern
EEG-EMG Zeitschrift Fur Elektroenzephalographie, Elektromyographie Und Verwandte Gebiete|March 1, 1981
[The use of electrophysiological techniques to project typical psychotropic drug effects: some examples (author's transl)]W M Herrmann, S Kubicki
Pharmacopsychiatry|July 1, 1996
Effect and efficacy--on the function of models in controlled phase III trials and the need for prospective pharmacoepidemiological studiesG Winterer, W M Herrmann
Pharmacopsychiatria|September 1, 1983
An absolute must in clinico-pharmacological research: pharmaco-electroencephalography, its possibilities and limitationsW M Herrmann, U Irrgang
Neuropsychobiology|January 1, 1986
Combined pharmaco-EEG and pharmacopsychological study to estimate CNS effects of ketanserin in hypertensive patientsW M Herrmann, P Baumgartner
Neuropsychobiology|January 1, 1990
Event-related potentials and the prediction of differential drug response in psychiatryU Hegerl, W M Herrmann
Pharmacopsychiatry|September 1, 1988
Psychostimulants, analeptics, nootropics: an attempt to differentiate and assess drugs designed for the treatment of impaired brain functionsH Coper, W M Herrmann
Pageof 12